Viewing Study NCT02025803


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-02 @ 9:17 AM
Study NCT ID: NCT02025803
Status: COMPLETED
Last Update Posted: 2024-09-05
First Post: 2013-12-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors
Sponsor: Taiho Oncology, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-11
Start Date Type: None
Primary Completion Date: 2017-07-07
Primary Completion Date Type: ACTUAL
Completion Date: 2017-07-07
Completion Date Type: ACTUAL
First Submit Date: 2013-12-27
First Submit QC Date: None
Study First Post Date: 2014-01-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-30
Last Update Post Date: 2024-09-05
Last Update Post Date Type: ACTUAL